-
Nephros Announces Results for Quarter Ended June 30, 2021
[ad_1] Second Quarter Net Revenue of $2.3 Million; 44% Year-Over-Year Increase; Strategic Acquisition of GenArraytion, Inc.; HDF Product Submitted to…
Read More » -
News
Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER
[ad_1] San Clemente, CA – (NewMediaWire) – August 06, 2021 – Nunzi Pharmaceutical Corporation (OTC:NUNZ) entered into a License Agreement…
Read More » -
News
GLOBAL ARENA HOLDING Will Host Webinar to Clarify Discussion Points of Upcoming Annual Stockholders Meeting
[ad_1] New York, NY – (NewMediaWire) – August 06, 2021 – Global Arena Holding, Inc. (the “Company”) (OTC Markets:GAHC), a growth…
Read More » -
Aemetis Receives Final Permit to Build Next 21 Miles of Phase 2 Biogas Pipeline
[ad_1] Fully Permitted to Begin Construction of 21 Miles of Phase 2 Biogas Pipeline in Stanislaus County, Calif. CUPERTINO, CA…
Read More » -
Aemetis to Review Second Quarter Financial Results on August 12, 2021
[ad_1] CUPERTINO, CA – (NewMediaWire) – August 5, 2021 – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host…
Read More »